Ted Cruz questions Netflix and Warner Bros. execs in Senate: 'Are we right now on stolen land'

Netflix's proposed $82.7 billion acquisition of Warner Bros. Discovery faced intense Senate scrutiny over competition and cultural questions, with lawmakers led by antitrust subcommittee chair Mike Lee warning the deal could reduce streaming competition, limit jobs, and enable Netflix to divert films from theaters. The DOJ is reviewing the transaction amid a competing hostile bid from Paramount Skydance, and congressional concern raises regulatory risk that could materially affect deal approval, content access and valuations for the companies involved.

Analysis

Market structure: A combined NFLX+WBD would concentrate marquee IP (Harry Potter, DC, Game of Thrones) behind a single global SVOD platform, improving negotiating leverage vs. distributors and studios and potentially adding 3–7% incremental US streaming share and 100–300bp ARPU upside over 2–4 years if content windows collapse. Losers: independent streamers and theatrical distributors that rely on Warner releases; winners: platform owners able to monetize franchises (WBD creditors/acquirers) and ad-supported video channels if Netflix leans hybrid. Expect intensified price/mix competition and re‑licensing frictions for 12–36 months post-close.

Risk assessment: Primary tail risks are a DOJ/FTC injunction/block (probability 20–40%), forced divestiture (15–30%), or a bidding war that leaves acquirer overlevered (Paramount-style debt risk) — any of which could move NFLX implied vol +40–80% and widen WBD credit spreads 100–300bp. Immediate (days): headline-driven equity volatility; short-term (3–9 months): regulatory review and potential litigation; long-term (1–3 years): realized synergies or structural rollback of content windows. Hidden dependency: third-party licensing contracts and talent deals with change-of-control triggers could strand content value.

Trade implications: Tactical: short-dated (3-month) bearish put spreads on NFLX sized 1–2% NAV to capture regulatory downside; simultaneous long WBD equity or 9–12 month call exposure 2–4% to play breakup/strategic sale upside. Pair trade: dollar‑neutral long WBD / short NFLX (1:1) to capture relative arbitrage around DOJ decisions. Options: buy NFLX 90‑day 10–20% OTM puts if DOJ files suit; sell short-dated WBD covered calls to finance carry.

Contrarian angles: The market prices a high probability of full block; underappreciated is a negotiated remedy (asset carve‑outs or behavioral fixes) leaving most franchise value with the acquirer — that would spur a >20% rerating in NFLX and a meaningful takeover premium in WBD. Conversely, if Netflix overpays or funds with equity, dilution risk could compress NFLX EPS by 5–15% in year‑1. Historical parallel: AT&T/Time Warner faced suit but closed with remedies — outcomes hinge on DOJ appetite and precise market definition (subscription vs. total TV viewing).

Key Decisions for Investors

• Establish a 1.5% NAV bearish position in NFLX via a 3‑month bear put spread (buy 1 ATM put, sell 1 10% OTM put) to limit max loss while capturing regulatory downside; reassess if DOJ files suit within 90 days and increase to 3% NAV.
• Take a 2–3% NAV long position in WBD equity or 9–12 month LEAP calls (delta ~0.40) to capture breakup/strategic sale premium; finance by selling 1–2 month covered calls to collect premium until regulatory clarity.
• Initiate a dollar‑neutral pair trade: long WBD / short NFLX sized 1–2% NAV each to exploit relative mispricing around hearings; trim by 25% on any 15% one‑day move against the pair.
• If DOJ/FTC files suit (trigger = public complaint within next 90–180 days), buy additional NFLX downside protection: 6‑month 15% OTM puts equal to 1–2% NAV and reduce long WBD exposure by half if WBD debt funding risk increases.
• Monitor three specific catalysts over the next 60–180 days: (1) DOJ/FTC public filing or second‑request timing, (2) Netflix/Warner disclosures on integration plans and anticipated divestitures, and (3) third‑party licensing change‑of‑control notices — act within 5 trading days of any catalyst release.